| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®
|
Pokladnikova, Jitka
|
|
2016
|
39 |
5 |
p. 455-464
|
artikel
|
| 2 |
An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval
|
Lorberbaum, Tal
|
|
2016
|
39 |
5 |
p. 433-441
|
artikel
|
| 3 |
Authors’ Reply to Montastruc et al.: “Drug-Induced Hyperglycaemia and Diabetes”
|
Fathallah, Neila
|
|
2016
|
39 |
5 |
p. 467
|
artikel
|
| 4 |
Comment on: “Drug-Induced Hyperglycaemia and Diabetes”
|
Montastruc, Jean-Louis
|
|
2016
|
39 |
5 |
p. 465-466
|
artikel
|
| 5 |
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases
|
Mascolo, Annamaria
|
|
2016
|
39 |
5 |
p. 401-407
|
artikel
|
| 6 |
Evidence of Misclassification of Drug–Event Associations Classified as Gold Standard ‘Negative Controls’ by the Observational Medical Outcomes Partnership (OMOP)
|
Hauben, Manfred
|
|
2016
|
39 |
5 |
p. 421-432
|
artikel
|
| 7 |
Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients
|
Baksh, Sheriza N.
|
|
2016
|
39 |
5 |
p. 375-380
|
artikel
|
| 8 |
Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them?
|
Slattery, Jim
|
|
2016
|
39 |
5 |
p. 371-373
|
artikel
|
| 9 |
Safety Profile of Atorvastatin 80 mg: A Meta-Analysis of 17 Randomized Controlled Trials in 21,910 Participants
|
Li, Haixia
|
|
2016
|
39 |
5 |
p. 409-419
|
artikel
|
| 10 |
Side Effects and Efficacy of Neuraxial Opioids in Pregnant Patients at Delivery: A Comprehensive Review
|
Armstrong, Sarah
|
|
2016
|
39 |
5 |
p. 381-399
|
artikel
|
| 11 |
Social Media Listening for Routine Post-Marketing Safety Surveillance
|
Powell, Gregory E.
|
|
2016
|
39 |
5 |
p. 443-454
|
artikel
|
Tijdschrift beschrijving